Which Israeli cancer treatment company raised $57 million and who is making money off double chins?
CTech Daily Roundup: Medtronic invests $4.5 million as part of BioProtect $25 million series D
Biological cancer treatment company Novellus raises $57 million. Novellus develops a drug that delays the development of a BRAF gene mutation created in cases of thyroid cancer and glioma cancer. Read more
Doctors. Photo: AFP Aurora Labs sees investors compete to take part in $23 million funding round. The Israeli autotech company offers easy updates to connected vehicle software, seeks expansion into IoT devices. Read more
Citi Foundation expands its entrepreneurship efforts in Israeli Arab minority with almost $500,000 grant to PresenTense. The Citi Foundation has committed $100 million over three years to help marginalized communities enter the workforce. Read more
Tel Aviv-based digital applications startup EasySend raises $11 million. EasySend develops a no-code drag and drop platform for managing customer experience by converting manual forms and data collection processes into digital mobile or web applications. Read more
Appointments | Facebook exec joins NFX to help steer startups on the right path. Morgan Beller was the co-founder of Libra and Head of Strategy for the company’s blockchain digital wallet, Novi. Read more
Synel launches new heat camera to help compliance with government. Covid-19 restrictions. As each country implements its own strategies to combat coronavirus, Israel-based Synel can help institutions and buildings protect their employees. Read more
Round B | Covid-19 highlights just how far bureaucracy has to go in terms of digitization. When deals in the hundreds of millions of dollars are sealed in an email, do we really need to personally submit dozens of manually filled out, signed, and stamped forms just to open a bank account? Read more
Double-chin reducing Israeli startup closes $74 million China licensing deal. The agreement provides JuveStar with exclusive rights to develop and commercialize Raziel Therapeutics’ proprietary RZL-012 compound. Read more
Tel Aviv set to ban entry of polluting vehicles. Municipality and Ministry of Environmental Protection plan to ban the entrance of polluting cars to Israel’s commercial capital within a year. Read more
Appointments | SimilarWeb appoints Kevin Spurway and Ron Asher as CMO and CTO. The new additions to the executive leadership team will report to CEO Or Offer. Read more
Medasense raises $18 million to expand the reach of its pain-detecting technology. The Israeli company uses sensors to objectively measure and monitor the patient’s physiological response to the pain that they are feeling. Read more
Tech@Work | This year tested our values and culture, admits HoneyBook’s HR Team. As part of our post-Covid HR series, HoneyBook’s Maya Wolkoon and Allie Mintz discuss how they foster a unified work environment from two main offices in Tel Aviv and San Francisco. Read more
Appointments | SentinelOne hires new CFO as IPO looms. The cyber company is coming off a $200 million Series E funding at a valuation of $1.1 billion and should it complete an IPO its value is expected to increase considerably. Read more
